Using patented devices from Germany (MBST) and Switzerland (CTU), our goal is to provide painless and stress-free treatment options
for patients to maintain healthy joints and bones. Both technologies work at the cellular level, using nuclear magnetic
resonance (MBST) and diamagnetic resonance (CTU) to stimulate regenerative processes by transferring energy into the
tissue cells, ultimately heal and relieve symptoms.
These are non-invasive, risk-free therapies that are used worldwide with no known side effects. Studies have indicated that patients suffering from pain associated with osteoarthritis have reported a reduction in pain levels after therapy. Other clinical studies have shown an increase in bone mass density after Magnetic Resonance Therapy.
A healthy body regulates the regeneration of cells and tissues with its own signal, which is controlled by electric and
magnetic fields. But when tissue such as cartilage is damaged, the signal is interrupted by this malfunction and often
inhibits regeneration and repair. This will often result in pain and/or reduced joint mobility.
Our treatment uses the proven technology to redirect signals to the damaged area to stimulate the regeneration of cells. This allows healing, thus reducing the damage done.
Medical trials have shown that the reactivation of cartilage regeneration within the joints reduces chronic discomfort and distinctly improves joint mobility.
Our treatments have been well established in the European countries with clinically proven results. The MBST is currently used in 39 countries, including France, Germany, Spain, United Kingdom and Singapore, first in Asia. It has received numerous awards and accolades for its continuous innovation since its development 20 years ago.